JORDYN MANUEL: Open Payments
NPI 1598424632 · METAIRIE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,582 in 76 payments from 24 companies in 2025. Trend: 2023 $97 · 2024 $503 · 2025 $1,582
Food & beverage: $1,582
| Company | Payments | Amount |
|---|---|---|
| Calliditas Therapeutics US Inc. | 8 | $194 |
| Otsuka America Pharmaceutical, Inc. | 8 | $183 |
| Bayer Healthcare Pharmaceuticals Inc. | 11 | $172 |
| Mallinckrodt Hospital Products Inc. | 9 | $171 |
| Fresenius USA Marketing, Inc. | 6 | $131 |
| Vifor Pharma, Inc. | 4 | $85 |
| Novartis Pharmaceuticals Corporation | 3 | $77 |
| NxStage Medical, Inc. | 1 | $76 |
| Lilly USA, LLC | 3 | $56 |
| Novo Nordisk Inc | 3 | $52 |
Products named: TARPEYO, Kerendia, JYNARQUE, ACTHAR, VELPHORO, Veltassa, Fabhalta, NXSTAGE SYSTEM ONE.
Industry payments across LA — which companies pay providers there.
